Zacks Small Cap Analysis – IMNN: IND Utility Submitted for Section 1/2 Trial of Seasonal COVID-19 Vaccine… – Model Slux
By David Bautz, PhD NASDAQ:IMNN READ THE FULL IMNN RESEARCH REPORT Enterprise Replace Replace on IMNN-101 Imunon, Inc. (NASDAQ:IMNN) is growing IMNN-101, which is a COVID-19 seasonal vaccine booster based mostly on the corporate’s PlaCCine know-how. It’s a DNA vaccine that addresses plenty of limitations of present vaccines, together with the sturdiness of antigen expression, … Read more
